Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Fri, Dec 19, 2025 07:39 PM All times are UTC

Follow Series

©Econometrics LLC . All Rights Reserved.

Barbara Mintzes

Dr Barbara Mintzes is a research scientist specialising in the study of pharmaceutical policy. Her research focuses on the effects of direct-to-consumer advertising of prescription drugs and other forms of pharmaceutical promotion on the prescribing and use of medicines. She also performs systematic reviews of clinical trial evidence regarding the health effects of medicines, including both benefit and harm, in terms of outcomes of importance to patients’ health. Dr Mintzes has has a doctorate in Health Care and Epidemiology and was Associate Professor at the School of Population and Public Health at the University of British Columbia (UBC), Canada prior to joining the University of Sydney in April 2015. At UBC, she worked with the Therapeutics Initiative, a research group that evaluates new drugs as a background to provincial reimbursement decisions and produces an educational bulletin on drug treatments. Currently, she is the lead investigator on an international comparative study examining the influence of national regulations on the amount of safety information that pharmaceutical sales representatives provide to primary care physicians. Dr Mintzes was a lead member of an international WHO and Health Action International (HAI) project that involved developing an educational manual on drug promotion, for pharmacy and medical students. This manual has been translated into Spanish, Russian and French, and incorporated into education curricula in a range of settings. Dr Mintzes maintains strong community engagement, having worked for many years with women’s health and consumer groups, including DES (diethylstilbestrol) Action Canada, and Women and Health Protection (a Canadian non-profit organization). She co-authored the book “Sex, Lies and Pharmaceuticals” with Ray Moynihan, published in 2010.

We can't trust drug companies to wine, dine and educate doctors about the drugs they prescribe

Apr 07, 2016 05:40 am UTC| Insights & Views Law

If a drug company treats a doctor to a nice lunch and a presentation on their newest products, is prescribing affected? Doctors generally think not, but the research evidence overwhelmingly says yes. And if these events do...

Economy

EU Delays Mercosur Free Trade Agreement Signing Amid Ukraine War Funding Talks

The European Union has decided to delay the formal signing of its long-anticipated free trade agreement with the Mercosur bloc, as EU leaders convened in Brussels to prioritize discussions on funding Ukraines war effort....

Precious Metals Rally as Silver and Platinum Outperform on Rate Cut Bets

Gold prices edged slightly lower in Asian trading on Friday but were still on track to post modest weekly gains, as strong safe-haven demand continued to support the precious metals market. At the same time, silver and...

Oil Prices Steady in Asia but Headed for Weekly Loss on Supply Glut Concerns

Oil prices were mostly steady during Asian trading on Friday, but both major benchmarks were still on track to record a second consecutive weekly decline as persistent concerns over a global supply glut continued to...

New Zealand Business Confidence Hits 30-Year High as Economic Outlook Improves

New Zealands business confidence surged sharply in December, reaching its highest level in three decades, according to the latest ANZ Bank Business Outlook survey released on Friday. The data highlights growing optimism...

BOJ Poised for Historic Rate Hike as Japan Signals Shift Toward Monetary Normalization

The Bank of Japan (BOJ) is widely expected to raise interest rates to a three-decade high, marking another milestone in its gradual exit from ultra-loose monetary policy. At the conclusion of its two-day meeting on Friday,...

Politics

U.S. and China Push for Ceasefire as Thailand–Cambodia Border Clashes Escalate

China and the United States are intensifying separate diplomatic efforts to revive a ceasefire between Thailand and Cambodia, as Southeast Asian leaders prepare for a crucial ASEAN meeting aimed at addressing the worst...

Syria, Kurds and U.S. Race to Show Progress on SDF Integration Deal

Syrian, Kurdish and U.S. officials are intensifying diplomatic efforts ahead of a year-end deadline to demonstrate progress on a long-stalled agreement to integrate Kurdish-led forces into the Syrian state, according to...

Putin Signals Possible Peace or Continued War in Ukraine at Major Year-End Address

Russian President Vladimir Putin is expected to send a significant signal to the United States and European powers regarding the future of the Ukraine war when he speaks at his annual end-of-year news conference on Friday....

Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy

The U.S. government under President Donald Trump has launched a formal review that could pave the way for the first-ever shipments of Nvidias H200 artificial intelligence chips to China, according to multiple sources...

Trump Signs Order to Ease Federal Marijuana Rules, Signaling Major Policy Shift

U.S. President Donald Trump has signed an executive order directing federal agencies to loosen regulations on marijuana, a move that could mark one of the most significant changes in U.S. cannabis policy in decades. The...

Science

Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency

The U.S. Senate has officially confirmed billionaire private astronaut Jared Isaacman as the new NASA administrator, making him the 15th leader in the agencys history. The confirmation, which took place on Wednesday, marks...

Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman

The U.S. Senate Commerce Committee announced it will vote on December 8 on President Donald Trumps renewed nomination of private astronaut and tech entrepreneur Jared Isaacman to lead NASA. Isaacman, known for his...

NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead

NASA has significantly scaled back Boeings Starliner program after years of technical issues and delays, announcing that the next Starliner mission to the International Space Station (ISS) will fly without astronauts. The...

Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission

Blue Origins massive New Glenn rocket marked a major milestone as it completed its first mission for paying customers, sending two NASA satellites toward Mars and successfully landing its reusable booster at sea. The...

Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment

Cogent Biosciences (NASDAQ: COGT) shares skyrocketed over 120% after the biotech company announced groundbreaking results from its Phase 3 PEAK trial evaluating bezuclastinib in combination with sunitinib for patients with...

Technology

TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement

TikTok has taken a major step toward securing its future in the United States after its Chinese parent company, ByteDance, announced it has signed binding agreements with three major investors to form a new joint venture...

Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz

Oracle Corporation (NYSE: ORCL) shares surged sharply in extended trading on Thursday, reflecting renewed investor optimism fueled by reports of a potential U.S. TikTok transaction and fresh fundraising discussions...

Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law

Apple has announced a major shift in its App Store policies in Japan, opening iPhones and other Apple devices to alternative app stores in order to comply with new competition laws aimed at reshaping the countrys...

Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand

Micron Technology delivered record first-quarter results and issued a bullish forecast for the current quarter, driven by rising memory prices and strong demand linked to artificial intelligence workloads. The upbeat...

Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track

Oracle shares fell more than 4% on Wednesday after a Financial Times report claimed that Blue Owl Capital, Oracles largest U.S. data center partner, decided not to support a planned $10 billion data center project in...